Tirzepatide is a groundbreaking pharmaceutical agent for individuals battling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://iannpcu049999.bloggerswise.com/48858570/tirzepatide-a-game-changer-for-type-2-diabetes